25.82
0.81 (3.24%)
0.81 (3.24%)
Upgrade to Real-Time
Afterhours (Closed)
Low
24.50
High
54.2081
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Iovance Biotherapeutics Inc | IOVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.81 | 3.24% | 25.82 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 25.32 | 25.23 | 27.00 | 25.82 | 25.01 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 25.00 | 30.78 | 5.78 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 25,142 | 2,157,285 | $ 26.13 | $ 56,359,789 | 2,233,661 | 24.50 - 54.2081 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:26:47 | 10 | $ 27.11 | USD |
Iovance Biotherapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 3.95B | 152.85M | 127.68M | $ - | $ - | -1.89 | -14.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 150.00k | 13.60% |
Iovance Biotherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IOVA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 29.93 | 30.82 | 24.50 | 26.51 | 2,700,469 | -4.11 | -13.73% |
| 1 Month | 33.23 | 33.55 | 24.50 | 29.53 | 2,153,413 | -7.41 | -22.3% |
| 3 Months | 47.31 | 47.50 | 24.50 | 31.77 | 2,199,116 | -21.49 | -45.42% |
| 6 Months | 38.00 | 54.2081 | 24.50 | 37.05 | 1,695,047 | -12.18 | -32.05% |
| 1 Year | 33.56 | 54.2081 | 24.50 | 34.48 | 1,636,466 | -7.74 | -23.06% |
| 3 Years | 15.20 | 54.2081 | 7.26 | 24.80 | 1,502,327 | 10.62 | 69.87% |
| 5 Years | 4.99 | 54.2081 | 4.45 | 22.35 | 1,092,227 | 20.83 | 417.43% |
Iovance Biotherapeutics Description
| Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. It's lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma. |
